{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T20:11:40Z","timestamp":1772741500075,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Austrian MPS Society"},{"DOI":"10.13039\/100013927","name":"National MPS Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013927","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004075","name":"The Jacob Randall Foundation for Morquio","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004075","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bennett Foundation"},{"name":"International Morquio Organization"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["8P20 GM103464-08"],"award-info":[{"award-number":["8P20 GM103464-08"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.ymgme.2014.05.013","type":"journal-article","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T07:16:45Z","timestamp":1401866205000},"page":"195-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Enzyme replacement therapy in newborn mucopolysaccharidosis IVA mice: Early treatment rescues bone lesions?"],"prefix":"10.1016","volume":"114","author":[{"given":"Shunji","family":"Tomatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana M.","family":"Monta\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vu Chi","family":"Dung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amiko","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Oguma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica L.","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadao","family":"Orii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William S.","family":"Sly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2014.05.013_bb0005","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/hmg\/ddm353","article-title":"Enzyme replacement therapy in a murine model of Morquio A syndrome","volume":"17","author":"Tomatsu","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0010","first-page":"65","article-title":"Current and emerging treatments and surgical interventions for Morquio A syndrome: a review","volume":"2","author":"Tomatsu","year":"2012","journal-title":"Res. Rep. Endocr. Disord."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF00206770","article-title":"An update on the frequency of mucopolysaccharide syndromes in British Columbia","volume":"85","author":"Lowry","year":"1990","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0020","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1542\/peds.105.1.e10","article-title":"Incidence of inborn errors of metabolism in British Columbia. 1969\u20131996","volume":"105","author":"Applegarth","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2014.05.013_bb0025","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s004390050641","article-title":"Incidence of the mucopolysaccharidoses in Northern Ireland","volume":"101","author":"Nelson","year":"1997","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in The Netherlands","volume":"105","author":"Poorthuis","year":"1999","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ymgme.2014.05.013_bb0040","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.ejhg.5201044","article-title":"Prevalence of lysosomal storage diseases in Portugal","volume":"12","author":"Pinto","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0045","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10545-005-0112-z","article-title":"Cumulative incidence rates of the mucopolysaccharidoses in Germany","volume":"28","author":"Baehner","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0050","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymgme.2013.04.002","article-title":"Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA","volume":"110","author":"Hendriksz","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0055","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10545-007-0529-7","article-title":"International Morquio A Registry: clinical manifestation and natural course of Morquio A disease","volume":"30","author":"Monta\u00f1o","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0060","series-title":"Handbook of Growth Monitoring and Health and Disease","article-title":"Chapter 126: impairment of body growth in mucopolysaccharidoses","author":"Tomatsu","year":"2012"},{"key":"10.1016\/j.ymgme.2014.05.013_bb0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ymgme.2013.06.007","article-title":"Newborn screening and diagnosis of mucopolysaccharidoses","volume":"110","author":"Tomatsu","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0070","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1517\/21678707.2013.846853","article-title":"Therapies of mucopolysaccharidosis IVA (Morquio A syndrome)","volume":"10","author":"Tomatsu","year":"2013","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.ymgme.2014.05.013_bb0075","article-title":"Morquio A syndrome: diagnosis and current and future therapies","volume":"12","author":"Tomatsu","year":"2014","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0080","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1651-2227.2009.01134.x","article-title":"Sacral dimple: incidental findings from newborn evaluation. Mucopolysaccharidosis IVA disease","volume":"98","author":"Ohashi","year":"2009","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0085","doi-asserted-by":"crossref","DOI":"10.1007\/8904_2014_298","article-title":"Mortality in patients with Morquio syndrome A","author":"Lavery","year":"2014","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0090","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ymgme.2013.04.009","article-title":"Pathogenesis of Morquio A syndrome: an autopsied case reveals systemic storage disorder","volume":"109","author":"Yasuda","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0095","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1093\/hmg\/ddg366","article-title":"Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns\u2212\/\u2212) produced by targeted disruption of the gene defective in Morquio A disease","volume":"12","author":"Tomatsu","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0100","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1093\/hmg\/ddi364","article-title":"Development of MPS IVA mouse (Galnstm(hC79S\u00b7mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase","volume":"14","author":"Tomatsu","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ymgme.2007.02.009","article-title":"Murine model (Galnstm(C76S)sl)) of MPS IVA with missense mutation at the active site cysteine conserved among sulfatase proteins","volume":"91","author":"Tomatsu","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10545-012-9522-x","article-title":"Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII","volume":"36","author":"Rowan","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0115","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2014macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2014.05.013_bb0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1023\/A:1012440428282","article-title":"Lessons learned from the development of enzyme therapy for Gaucher disease","volume":"24","author":"Barranger","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0125","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ymgme.2014.05.013_bb0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2014replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0135","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme-replacement therapy in mucopolysaccharidosis I","volume":"344","author":"Kakkis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0140","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0145","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jpeds.2004.03.018","article-title":"Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux\u2013Lamy syndrome)","volume":"144","author":"Harmatz","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0150","doi-asserted-by":"crossref","first-page":"e681","DOI":"10.1542\/peds.2004-1023","volume":"115","author":"Harmatz","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2014.05.013_bb0155","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jpeds.2005.12.014","volume":"148","author":"Harmatz","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0160","doi-asserted-by":"crossref","DOI":"10.1007\/s10545-014-9715-6","article-title":"Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study","author":"Hendriksz","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0165","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1096-7192(03)00007-6","article-title":"Replacement therapy in mucopolysaccharidosis type VI: advantages of early onset of therapy","volume":"78","author":"Auclair","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ymgme.2012.07.002","article-title":"Long circulating enzyme replacement therapy rescues bone pathology in mucopolysaccharidosis VII murine model","volume":"107","author":"Rowan","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0175","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10024-005-0025-8","article-title":"Early onset of lysosomal storage disease in a murine model of mucopolysaccharidosis type VII: undegraded substrate accumulates in many tissues in the fetus and very young MPS VII mouse","volume":"8","author":"Vogler","year":"2005","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0180","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1172\/JCI117237","article-title":"Enzyme replacement therapy for murine mucopolysaccharidosis type VII","volume":"93","author":"Sands","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0185","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1203\/00006450-199606000-00019","article-title":"Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival","volume":"39","author":"Vogler","year":"1996","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0190","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1023\/A:1005423222927","article-title":"Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease","volume":"21","author":"Vogler","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2014.05.013_bb0195","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ymgme.2012.03.022","article-title":"Skeletal response to lentiviral mediated gene therapy in a mouse model of MPS VII","volume":"106","author":"Macsai","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0200","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1006\/mthe.2002.0809","article-title":"Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy","volume":"6","author":"Lingfei","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0205","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0092-8674(03)00347-7","article-title":"Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(alpha)-formylglycine generating enzyme","volume":"113","author":"Dierks","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.ymgme.2014.05.013_bb0210","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0092-8674(03)00348-9","article-title":"The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases","volume":"113","author":"Cosma","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.ymgme.2014.05.013_bb0215","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-1119(03)00746-7","article-title":"The human SUMF1 gene, required for posttranslational sulfatase modification, defines a new gene family which is conserved from pro- to eukaryotes","volume":"316","author":"Landgrebe","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.ymgme.2014.05.013_bb0220","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ymgme.2007.01.004","article-title":"Characterization and pharmacokinetic study of recombinant human N-acetylgalactosamine-6-sulfate sulfatase","volume":"91","author":"Tomatsu","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0225","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0009-8981(90)90339-T","article-title":"A fluorimetric enzyme assay for the diagnosis of Morquio disease type A (MPS IV A)","volume":"187","author":"van Diggelen","year":"1990","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2014.05.013_bb0230","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0003-2697(79)90222-7","article-title":"Review of the Folin phenol protein quantitation method of Lowry, Rosebrough, Farr and Randall","volume":"100","author":"Peterson","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0245","doi-asserted-by":"crossref","first-page":"14777","DOI":"10.1073\/pnas.0506892102","article-title":"Overcoming the blood\u2013brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII","volume":"102","author":"Vogler","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0250","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1203\/01.PDR.0000129661.40499.12","article-title":"Enzyme-replacement therapy from birth delays the development of behavior and learning problems in mucopolysaccharidosis type IIIA mice","volume":"56","author":"Gliddon","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0255","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1203\/00006450-199312000-00028","article-title":"Enzyme replacement with recombinant beta-glucuronidase in the newborn mucopolysaccharidosis type VII mouse","volume":"34","author":"Vogler","year":"1993","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0260","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/mt.2010.32","article-title":"Enhancement of drug delivery: enzyme replacement therapy for murine Morquio A syndrome","volume":"18","author":"Tomatsu","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2014.05.013_bb0265","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/pd.1970121207","article-title":"Fetal presentation of Morquio disease type A","volume":"12","author":"Beck","year":"1992","journal-title":"Prenat. Diagn."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214001851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214001851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:16:31Z","timestamp":1589242591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719214001851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1096719214001851"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.05.013","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enzyme replacement therapy in newborn mucopolysaccharidosis IVA mice: Early treatment rescues bone lesions?","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}